Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2022 01:00 ET | Source: NMD Pharma

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead clinical programs, expand the number of...
July 08, 2021 07:00 ET | Source: NMD Pharma

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...
July 08, 2021 02:00 ET | Source: NMD Pharma

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in collaboration with Aarhus University and...
June 30, 2021 07:00 ET | Source: NMD Pharma

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 Aarhus, Denmark, 30 June 2021 – NMD Pharma A/S, a biotech company leading in the development...
June 30, 2021 02:00 ET | Source: NMD Pharma

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 Aarhus, Denmark, 30 June 2021 – NMD Pharma A/S, a biotech company leading in the development...
June 01, 2021 07:00 ET | Source: NMD Pharma

NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults

PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...
June 01, 2021 02:00 ET | Source: NMD Pharma

NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults

PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Aarhus, Denmark, 1 June 2021 – NMD Pharma A/S,...
November 30, 2020 01:00 ET | Source: NMD Pharma

NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth

NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth Aarhus, Denmark, 30 November 2020 – NMD Pharma A/S, a biotech company leading in the development of novel therapeutics for...
October 06, 2020 07:00 ET | Source: NMD Pharma

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis Aarhus, Denmark, 6 October 2020 – NMD Pharma A/S, a biotech company...
October 06, 2020 01:00 ET | Source: NMD Pharma

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis Aarhus, Denmark, 6 October 2020 – NMD Pharma A/S, a biotech company...